ALNYLAM PHARMACEUTICALS, INC. Accumulated OCI 2009-2025 | ALNY
Beta
What is accumulated oci?
Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.
What is ALNYLAM PHARMACEUTICALS, INC.'s current accumulated oci?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual accumulated oci for 2025 was $-20.1M, a 41.78% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. accumulated oci for the quarter ending December 31, 2025 was $-20.1M.
What was ALNYLAM PHARMACEUTICALS, INC.'s accumulated oci in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual accumulated oci for 2024 was $-34.5M, a 47.67% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s accumulated oci in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual accumulated oci for 2023 was $-23.4M, a 47.65% increase from 2022.
Accumulated OCI History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-43.6M
→
FY2025
$-20.1M
0910111213141516171819202122232425
5 years selected
Accumulated OCI History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-20.1M | +41.8% | 10-K |
| FY2024 | $-34.5M | -47.7% | 10-K |
| FY2023 | $-23.4M | +47.7% | 10-K |
| FY2022 | $-44.7M | -34.3% | 10-K |
| FY2021 | $-33.3M | +23.8% | 10-K |
| FY2020 | $-43.6M | -19.5% | 10-K |
| FY2019 | $-36.5M | -10.0% | 10-K |
| FY2018 | $-33.2M | +3.5% | 10-K |
| FY2017 | $-34.4M | -3.0% | 10-K |
| FY2016 | $-33.4M | -865.4% | 10-K |
| FY2015 | $4.4M | -91.0% | 10-K |
| FY2014 | $48.8M | +147.3% | 10-K |
| FY2013 | $19.7M | +25.9% | 10-K |
| FY2012 | $15.7M | +9592.1% | 10-K |
| FY2011 | $-165,000 | -123.1% | 10-K |
| FY2010 | $714,000 | -0.3% | 10-K |
| FY2009 | $716,000 | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →